Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The bone cement market was valued at USD 1871.10 Million in 2025. It is poised to grow at a CAGR of 6.50% during the forecast period of 2026-2035, and reach USD 3512.31 Million by 2035. The market growth is driven by the rising prevalence of osteoporosis, the expanding global volume of hip and knee arthroplasty procedures, growing adoption of vacuum-mixing and antibiotic-loaded formulations, and increasing minimally invasive interventions for vertebral compression fractures.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
6.5%
Value in USD Million
2026-2035
*this image is indicative*
Bone cement plays a vital role in modern orthopedic procedures by improving implant stability, supporting bone reconstruction, and enhancing surgical outcomes in joint replacement and trauma surgeries. The market is poised to grow at a CAGR of 6.50% during the forecast period of 2026-2035, supported by rising orthopedic surgical volumes and growing demand for durable joint fixation across hip and knee arthroplasty procedures. The shift toward antibiotic-loaded and high-viscosity cement formulations is improving infection prevention and handling characteristics, while integration with vacuum-mixing systems strengthens implant longevity and intraoperative safety. Continued advances in orthopedic implants and minimally invasive vertebral augmentation are further reinforcing market growth across primary and revision surgeries globally.
Market Breakup by Product
The market is segmented by product into polymethyl methacrylate (PMMA) cement, calcium phosphate cement, glass polyalkenoate cement, calcium sulphate-based cement, and others. PMMA cement is growing due to its decades-long clinical track record and dominant use across hip and knee arthroplasty for stable implant fixation, including procedures involving orthopedic prosthetics. Calcium phosphate cement is gaining traction in selected orthopedic applications where bioactive bone substitution and natural bone remodeling are clinically preferred.
Market breakup by Viscosity
The market is segmented by viscosity into low, medium, and high viscosity bone cement, with growing adoption supported by rising orthopedic surgeries, improved implant fixation performance, enhanced handling characteristics, and increasing demand for advanced joint replacement procedures globally.
Market Breakup by Application
The market is segmented by application into arthroplasty, vertebroplasty, kyphoplasty, trauma and fracture repair, and others, with growth supported by rising orthopedic surgeries, increasing osteoporosis prevalence, and growing adoption of minimally invasive bone stabilization procedures globally.
Market Breakup by End User
By end user, the market includes hospitals, orthopaedic clinics, ambulatory surgical centers, and other settings. Hospitals are expected to lead due to high orthopedic surgical volumes and the availability of advanced operating-room infrastructure, while ambulatory surgical centres are growing rapidly as outpatient joint replacement and spinal augmentation procedures expand. The shift toward outpatient knee replacement is reinforcing demand for streamlined cement delivery systems and pre-mixed formulations.
Market Breakup by Region
The market is segmented by region into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate due to advanced orthopedic infrastructure, high arthroplasty procedural volumes, and well-established reimbursement frameworks supporting hip replacement implants, while Asia Pacific is anticipated to expand rapidly with rising aging populations and broader access to elective hip replacement procedures.
| Analysis Type | Factors | Example |
| Market Drivers | Rising prevalence of osteoporosis and growing arthroplasty procedures. | According to the International Osteoporosis Foundation, over 200 million people globally are affected by osteoporosis-related conditions. |
| Market Restraints | Bone cement implantation syndrome, aseptic loosening, and supply disruptions continue to challenge orthopedic bone cement adoption rates. | In February 2026, Heraeus Medical reported packaging-related sterility concerns affecting bone cement supply availability across the UK. |
| Market Opportunities | Growing adoption of antibiotic-loaded and bioactive calcium phosphate cements is creating opportunities in orthopedic and trauma procedures. | In February 2026, Biocomposites launched SYNICEM bone cement in the UK to address orthopedic cement supply shortages. |
This section analyzes key factors influencing market growth, including disease burden, regulatory drivers, technology adoption, cost dynamics, and ecosystem shifts, while integrating interlinking keywords to highlight ecosystem-wide industry connections.
Rising Osteoporosis Burden and Arthroplasty Volumes Driving Market Growth
The market is witnessing strong growth driven by the rising global burden of osteoporosis and the steadily increasing volumes of joint replacement surgery across the arthroplasty segment, including procedures such as cementless total knee arthroplasty. According to the International Osteoporosis Foundation, more than 200 million people worldwide are affected by osteoporosis, with one in three women and one in five men over age 50 expected to experience an osteoporotic fracture in their lifetime. This growing disease burden and increasing demand for advanced orthopedic interventions are expected to continue supporting market expansion during the forecast period.
Bone Cement Implantation Syndrome and Supply Disruptions is Challenging the Market Growth
The risk of bone cement implantation syndrome, alongside concerns about aseptic loosening and PMMA-associated thermal injury, remains a notable clinical restraint, particularly in elderly patients undergoing hip arthroplasty. Supply continuity concerns also affect the segment, as highlighted by a British Orthopaedic Association advisory on packaging-related sterility concerns affecting Heraeus Medical bone cement pouches in the UK. However, ongoing advances in low-monomer formulations, vacuum-mixing systems, and pre-filled delivery kits are improving safety profiles and supporting sustained adoption across orthopedic and joint replacement procedures.
Antibiotic-Loaded Cements and Bioactive Calcium Phosphate Boosting the Market Expansion
The expansion of antibiotic-loaded bone cement formulations and bioactive calcium phosphate cements is creating significant growth opportunities, supported by improved infection prevention in revision arthroplasty and better integration with native bone in trauma indications. For instance, in February 2026, Biocomposites launched SYNICEM bone cement in the UK to address supply disruptions and strengthen access to orthopedic cement solutions, highlighting ongoing product expansion in the market. Recent developments also indicate increased focus on production expansion and innovation in PMMA-based bone cement, with manufacturers advancing regulatory submissions for high-viscosity and fast-setting variants designed for minimally invasive orthopedic procedures. These developments reinforce the role of advanced cements across the bone graft substitutes continuum, while supporting broader adoption of orthopedic prosthetics and expanding clinical use cases globally.
Rising Synthetic Bone Bioadhesives and Advanced Delivery Systems to Enhance Market Growth
The emergence of synthetic injectable bone bioadhesives is a key trend shaping the market, supported by FDA Breakthrough Device pathways and growing clinical demand for solutions to complex peri-articular fractures. In December 2025, Sanara MedTech and Biomimetic Innovations reaffirmed Q1 2027 plans for the U.S. commercial launch of OsStic, a phosphoserine, alpha-tricalcium phosphate, and calcium silicate-based bioadhesive that received FDA Breakthrough Device Designation in December 2023. Preclinical mechanical testing demonstrated bond strength approximately 40 times that of traditional calcium phosphate bone cement. These advancements are expected to support innovation in orthopedic fixation procedures and next-generation bone repair technologies during the forecast period.
PMMA Cement Likely to Dominate the Market Segment by Product Type
Polymethyl methacrylate (PMMA) cement is likely to lead the market, accounting for about 73% market share in the historical period. Polymethyl methacrylate (PMMA) cement is likely to lead the market, accounting for about 73% market share in the historical period. The market is segmented by product into polymethyl methacrylate (PMMA) cement, calcium phosphate cement, glass polyalkenoate cement, and other specialty bone cements. Among these, medical polymers-based PMMA cement is expected to maintain its dominance due to its superior mechanical strength, excellent fixation capability, and extensive use in orthopedic procedures such as joint arthroplasty and vertebroplasty. The increasing demand for durable implant fixation materials and the growing volume of orthopedic surgeries are further expected to support the continued expansion of the PMMA cement segment during the forecast period.
Among all the regions, North America is likely to witness substantial share of the market supported by advanced orthopedic infrastructure, high arthroplasty procedural volumes, and well-developed reimbursement frameworks across the United States and Canada. The region benefits from early adoption of antibiotic-loaded cements, vacuum-mixing systems, and pre-filled delivery kits, alongside the presence of leading orthopedic device companies. Additionally, the rising prevalence of osteoporosis-related fractures and the expanding role of the osteoporosis drug pipeline reinforce steady market growth.
Stryker Corporation, headquartered in Kalamazoo, Michigan, United States, was founded in 1941 and is a global leader in medical devices spanning orthopedics, neurotechnology, and surgical equipment. Its bone cement portfolio includes Simplex P, Surgical Simplex, and Cobalt HV/MV PMMA cements, alongside Cortoss for vertebral augmentation, reinforcing its strong position across the arthroplasty and spine segments.
Zimmer Biomet Holdings, Inc. is a leading orthopedic medical technology company actively involved in the bone cement market through its extensive portfolio of bone cements, vacuum mixing systems, cement spacer molds, and cement delivery solutions. The company offers products such as Refobacin® Bone Cement R, Biomet Bone Cement R, and ClearMix™ Vacuum Mixing System, supporting arthroplasty, implant fixation, and revision procedures while strengthening advanced cementing techniques in orthopedic surgeries globally.
Smith & Nephew plc, headquartered in London, United Kingdom, was founded in 1856 and operates across orthopedics, sports medicine, and advanced wound management. Its orthopedic reconstruction portfolio includes the SmartSet bone cement family, supporting hip and knee arthroplasty procedures globally and reinforcing its presence in the joint reconstruction segment.
Arthrex, Inc., headquartered in Naples, Florida, United States, was founded in 1981 and specializes in orthopedic surgical devices and biologic technologies. Its portfolio spans arthroscopy, sports medicine, and orthopedic biomaterials, including bone substitutes and fixation products that support orthopedic surgical workflows in joint reconstruction and trauma.
Other players in the market are DePuy Synthes, Heraeus Holding GmbH, Merck KGaA, Cardinal Health, Inc., Medtronic Plc, and Teknimed SAS.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Viscosity |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share